Dermatology · Houston, TX
NPI
1386696904
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2120 Ashland St
Houston, TX, 77008
Phone (713) 864-2659
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
17,927 services
Medicare patients, 2024
1,129
Average age 74
Drug cost, 2024
$1.7M
1,211 prescriptions
Company payments, 2025
$230K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alpesh D Desai was code G6001 (ultrasonic guidance for placement of radiation therapy fields), 3,951 times for 226 patients. In total Alpesh D Desai billed 17,927 services in 103 codes, and Medicare paid $2.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-09.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 3,951 | 226 | $141.52 | $559K |
| 77280 Radiation Treatment Planning | Office | 3,890 | 204 | $211.06 | $821K |
| 77401 Conventional Radiation Treatment | Office | 3,749 | 200 | $32.73 | $123K |
| 99213 Office E&M - Established | Office | 1,043 | 499 | $68.27 | $71K |
| 17003 Destruction Skin Lesion | Office | 737 | 159 | $4.90 | $3,611 |
| 77336 Radiation Treatment Planning | Office | 500 | 163 | $69.66 | $35K |
| 99214 Office E&M - Established | Office | 475 | 362 | $84.18 | $40K |
| 11102 Skin Biopsy | Office | 325 | 284 | $59.31 | $19K |
| 77300 Radiation Treatment Planning | Office | 319 | 181 | $52.57 | $17K |
| 17000 Destruction Skin Lesion | Office | 255 | 233 | $37.30 | $9,512 |
| 17004 Destruction Skin Lesion | Office | 230 | 164 | $124.79 | $29K |
| 17110 Destruction Skin Lesion | Office | 193 | 160 | $70.49 | $14K |
| 77332 Radiation Treatment Planning | Office | 185 | 113 | $31.36 | $5,801 |
| 11103 Skin Biopsy | Office | 164 | 111 | $39.42 | $6,464 |
| 77261 Radiation Treatment Planning | Office | 134 | 129 | $55.34 | $7,416 |
By year: 2022 $4.7M for 41,265 services; 2023 $2.0M for 19,431 services; 2024 $2.0M for 17,927 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alpesh D Desai prescribed most often to Medicare patients was Ketoconazole, with 133 prescriptions and refills. In total Alpesh D Desai wrote 1,211 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 133 | 148 | 72 | $2,040 |
| Mupirocin Generic | 105 | 105 | 77 | $789 |
| Triamcinolone Acetonide Generic | 102 | 108 | 67 | $1,255 |
| Doxycycline Hyclate Generic | 88 | 98 | 47 | $2,207 |
| Dupixent Pen Dupilumab | 81 | 91 | 20 | $339K |
| Mometasone Furoate Generic | 71 | 73 | 46 | $1,261 |
| Clobetasol Propionate Generic | 52 | 52 | 25 | $3,053 |
| Fluocinonide Generic | 47 | 54 | 31 | $1,740 |
| Humira(Cf) Pen Adalimumab | 42 | 42 | Under 11 | $331K |
| Enstilar Calcipotriene/Betamethasone | 41 | 63 | 21 | $72K |
| Clindamycin Phosphate Generic | 39 | 39 | 24 | $1,039 |
| Betamethasone Dipropionate Generic | 37 | 39 | 16 | $1,633 |
| Hydrocortisone Generic | 31 | 31 | 20 | $130 |
| Nystatin Generic | 28 | 28 | Under 11 | $279 |
| Cephalexin Generic | 28 | 28 | 28 | $194 |
Brand drugs: 298 claims; generic drugs: 913 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alpesh D Desai $230K ($230K in general payments such as food, travel and fees) from 21 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $107K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 42 | $107K |
| Genzyme Corporation SNY | 16 | $60K |
| Abbvie Inc. ABBV | 49 | $55K |
| Janssen Biotech, Inc. JNJ | 10 | $7,401 |
| LEO Pharma Inc. | 2 | $181 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $112 |
| Revance Therapeutics, Inc. | 1 | $107 |
| Galderma Laboratories, L.P. GALD.SW | 5 | $80.66 |
| Amgen Inc. AMGN | 3 | $49.23 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $45.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.